Volunteers Required for Malaria Infectivity Study

Published AuthorContributed
Institute for Glycomics are calling for volunteers to be part of their malaria vaccine study.

Griffith University is seeking healthy, non-smoker males aged 18-45 years to participate in a study at Robina Hospital examining the infectivity of malaria parasites in humans.

The results from this study are critical for further human clinical studies including the development of a malaria vaccine.

This study will involve administering malaria parasites in red blood cells to study participants and monitoring the development of the parasites in the blood. Anti-malarial medication will be administered once the malaria parasites reach a defined low level in the blood and before the onset of illness.

For further information, please contact Dr Danielle Stanisic on 5552 9433 or [email protected]

Institute for GlycomicsGriffith University

This study has been approved by the Griffith University Human Research Ethics committee (GLY/04/12/HREC) and the Gold Coast Hospital and Health Service HREC (HREC/12/QGC/142).

Related
Centre for Planetary Health and Food Security

Coffee, coastlines and a cutting-edge vaccine: Griffith’s Advanced Queensland trio putting state at forefront

Griffith researchers among 19 scientists share in $5.56 million of funding.
home

Global collaboration to combat chronic lung infection

Researchers develop drug target to tackle multi-drug resistant lung bacterium.
10 Reduced Inequalities

New Discovery Unravels Malaria Invasion Mechanism

In a significant breakthrough, researchers from the Swiss Tropical and Public Health Institute (Swiss TPH) and Griffith University’s Institute for Glycomics have unveiled a crucial aspect of how the malaria parasite infiltrates human red blood cells. The study, recently published in Cell Reports, highlights the pivotal role of a sugar known as sialic acid in […]
home

Funding to find repurposed drugs to fight bacterial infections

Griffith University will use a $2.95 million NHMRC grant to take a unique focus on targeting sugar interactions to prevent and treat bacterial infections that cause meningitis, pneumonia and gastrointestinal infections. Professor Michael Jennings from Griffith’s Institute for Glycomics was recently awarded the funding for his research into discovering and exploiting glycointeractions to create new […]